Introduction: Packaging material vendor audit MCQs With Answer is designed for M.Pharm students to deepen understanding of vendor qualification, regulatory expectations, and practical audit activities related to packaging materials. This collection emphasizes risk-based supplier assessment, documentation review, material compatibility, traceability, change control, stability considerations, and on-site verification of manufacturing and printing controls. The questions simulate real audit scenarios and decision points encountered during packaging supplier evaluations, helping students link theory with GMP-compliant practice. Answers are provided to reinforce learning and improve preparedness for conducting or participating in packaging material vendor audits within regulated pharmaceutical environments.
Q1. What is the primary objective of a packaging material vendor audit?
- To negotiate better pricing for packaging materials
- To ensure the vendor follows current Good Manufacturing Practices (GMP) and regulatory requirements ensuring material quality and traceability
- To obtain marketing materials for the product
- To train the vendor in pharmaceutical manufacturing
Correct Answer: To ensure the vendor follows current Good Manufacturing Practices (GMP) and regulatory requirements ensuring material quality and traceability
Q2. Which document should define the physical, chemical and functional attributes required for a packaging material?
- Purchase order
- Certificate of Analysis (CoA)
- Packaging material specification
- Invoice
Correct Answer: Packaging material specification
Q3. How should the frequency of vendor audits for packaging suppliers be determined?
- Every five years for all suppliers without exception
- Only once during initial qualification and never again
- Based on risk assessment; high-risk suppliers are audited annually and low-risk less frequently
- Whenever the procurement department requests it for cost reasons
Correct Answer: Based on risk assessment; high-risk suppliers are audited annually and low-risk less frequently
Q4. Which activity is least relevant when auditing a packaging material vendor?
- Reviewing the vendor’s batch release and COA procedures for packaging lots
- Inspecting storage, humidity control and pest control at the vendor site
- Reviewing the site’s master formula for the drug product
- Assessing traceability and batch coding practices for packaging materials
Correct Answer: Reviewing the site’s master formula for the drug product
Q5. What key elements should a quality agreement with a packaging supplier include?
- Only commercial terms and delivery schedules
- Specifications, responsibilities for testing and release, change control, CAPA and traceability
- Marketing responsibilities and co-promotion clauses
- Employee hiring practices
Correct Answer: Specifications, responsibilities for testing and release, change control, CAPA and traceability
Q6. During an audit you find that certificates of analysis for incoming printed labels do not match the supplier’s specification. What is the appropriate immediate action?
- Accept and use the materials because shipping schedules are tight
- Notify your QA, quarantine the affected lots and initiate investigation with the supplier
- Return the materials to the supplier without further review
- Change your specification to match the CoA
Correct Answer: Notify your QA, quarantine the affected lots and initiate investigation with the supplier
Q7. Which sampling approach is commonly recommended for incoming packaging material inspection?
- Statistically based sampling (e.g., ISO 2859 / AQL)
- Sampling only when visually suspicious
- Sample one unit per year
- No sampling is needed if supplier is approved
Correct Answer: Statistically based sampling (e.g., ISO 2859 / AQL)
Q8. Which of the following best describes a primary packaging material?
- Packaging used to group packed products for storage and transport
- Material that is in direct contact with the pharmaceutical product
- Outer carton used for palletization
- Shipping container or overpack
Correct Answer: Material that is in direct contact with the pharmaceutical product
Q9. When assessing suitability of packaging for long-term storage of a drug product, what should the auditor prioritize?
- Only the aesthetics and branding quality of the packaging
- Compatibility and stability data demonstrating no interaction with the drug and maintenance of barrier properties over shelf life
- Lowest-cost material regardless of properties
- How quickly the supplier can deliver samples
Correct Answer: Compatibility and stability data demonstrating no interaction with the drug and maintenance of barrier properties over shelf life
Q10. What vendor deliverable is critical to control artwork and label printing errors?
- Proof-of-print and approved artwork samples with version control
- Only verbal confirmation by the vendor
- Electronic invoice
- Supplier’s annual financial statement
Correct Answer: Proof-of-print and approved artwork samples with version control
Q11. What traceability information must be maintained for packaging materials?
- Only the supplier name is sufficient
- Unique batch/lot identification linked to supplier lot, delivery records and production/batch records
- Only the purchase order number
- Only shipping dates
Correct Answer: Unique batch/lot identification linked to supplier lot, delivery records and production/batch records
Q12. While auditing change control at a packaging supplier you should verify:
- That all changes are communicated by phone only
- Documentation of changes including impact assessment, approvals and notification to customers where required
- That no changes are ever allowed
- That changes are implemented without records to save time
Correct Answer: Documentation of changes including impact assessment, approvals and notification to customers where required
Q13. Which regulatory requirement directly addresses GMP expectations for finished pharmaceuticals and indirectly impacts packaging material control?
- 21 CFR Part 211 (cGMP for finished pharmaceuticals)
- ICH Q7 (API GMP guidance only)
- Codex Alimentarius
- Guideline on Good Laboratory Practice (GLP)
Correct Answer: 21 CFR Part 211 (cGMP for finished pharmaceuticals)
Q14. A finding where label print quality variance could cause patient safety risk should be classified as:
- Minor observation with no further follow-up
- Major nonconformity because it could affect product identification and patient safety
- Only a suggestion for improvement
- Not a concern if the supplier is otherwise compliant
Correct Answer: Major nonconformity because it could affect product identification and patient safety
Q15. Which qualifications are expected for a packaging/label printing line from a supplier?
- No qualifications are necessary
- Installation, Operational and Performance qualifications (IQ/OQ/PQ)
- Only a visual inspection upon delivery
- ISO 14001 certification only
Correct Answer: Installation, Operational and Performance qualifications (IQ/OQ/PQ)
Q16. Which of the following best represents an appropriate supplier selection criterion for packaging materials?
- Lowest cost exclusively
- Quality, technical capability, regulatory history and supply reliability
- Proximity to your office only
- Advertising and market popularity
Correct Answer: Quality, technical capability, regulatory history and supply reliability
Q17. What environmental controls are most important for paperboard or blister packaging storage at the vendor site?
- Controlled humidity, temperature, clean storage and pest control
- Only temperature control is needed
- Open-air storage is acceptable
- Lighting levels only
Correct Answer: Controlled humidity, temperature, clean storage and pest control
Q18. During an audit, verifying tamper-evident features on packaging should include checking:
- Presence, functionality and verification records of seals, holograms or tamper-evident closures and related testing
- Only the supplier’s marketing claims
- That packaging is colorful and attractive
- Only the cost of adding tamper features
Correct Answer: Presence, functionality and verification records of seals, holograms or tamper-evident closures and related testing
Q19. How often should a Certificate of Analysis (CoA) accompany packaging material deliveries to a pharmaceutical manufacturer?
- Only once at initial qualification
- With every delivered batch/lot of packaging material
- Only when requested by procurement
- Never—CoAs are unnecessary
Correct Answer: With every delivered batch/lot of packaging material
Q20. Which quality risk management tool is most appropriate to identify and prioritize failure modes related to packaging performance?
- SWOT analysis only
- Failure Mode and Effects Analysis (FMEA)
- Market trend analysis
- Simple majority voting
Correct Answer: Failure Mode and Effects Analysis (FMEA)
